BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, February 18, 2026
Home » Authors » Omar Ford

Articles by Omar Ford

MMIS says awareness still lacking in Sunshine Act

March 1, 2013
By Omar Ford

Biotronik receives FDA nod for Lumax 740 DX System

Feb. 28, 2013
By Omar Ford

Mind over matter

Feb. 27, 2013
By Omar Ford
She was probably a little more than 5-feet-tall... and close to 160 pounds of pure muscle. On a day unlike any other, I crossed the path of this 60-year-old woman (though she doesn't look a day over 40) who is an avid bodybuilder, at the gym I often work out in. We were both headed to a piece of equipment to do pull-ups - I was by myself, she was with a cadre of women that she was training. As I was about to get on the machine she cut me off rather quickly and hopped on it before I...
Read More

Financings roundup: TearScience secures up to $70M in funding from HRP

Feb. 27, 2013
By Omar Ford
TearScience (Morrisville, North Carolina), a privately held firm, said that it has secured up to $70 million in funding from HealthCare Royalty Partners to fully implement commercialization efforts and establish the TearScience system as the "standard of care" for evaporative dry eye.
Read More

Financings roundup: Intersect ENT completes its $30 million Series D funding

Feb. 26, 2013
By Omar Ford

SEMDA 2013: Shuren says FDA addressing concerns with review process

Feb. 25, 2013
By Omar Ford
ATLANTA — For years medical device makers have fired off concerns and criticisms of the FDA's regulatory process – at times going so far as to call it unpredictable. Last week, during the Southeastern Medical Device Association's (SEMDA; Norcross, Georgia) annual conference held at the Georgia Institute of Technology Global Learning Center (Atlanta), med-tech firms got the chance to hear directly from the Center for Devices and Radiological Health's (CDRH) director – Jeffrey Shuren.
Read More

SEMDA conference did not disappoint

Feb. 22, 2013
By Omar Ford
Earlier this week, I had the privilege of attending the Southeastern Medical Device Association's (SEMDA) annual conference. It was a tremendous opportunity to meet the players in the med-tech space that are located close to the office where  Medical Device Daily is published. I would have to say that this conference did not disappoint. The presentations were lively; the speakers were great and the topics were very relevant to the med-tech industry. Perhaps one of my most favorite speakers was Jon Ellenthal, a partner and President of TEDMED, a company focused on innovation and breakthrough thinking across all of health...
Read More

SEMDA 2013: A CEO's journey is roller coaster ride of successes and failures

Feb. 22, 2013
By Omar Ford
ATLANTA — Just what does it take to be a CEO of a successful med-tech startup? What does the journey look like for a CEO that has made it through the process of taking an idea and building a product and business around it? Those questions were answered during the CEO Roundtable, one of the more popular sessions at the Southeastern Medical Device Conference (SEMDA; Norcross Georgia) on Wednesday.
Read More

SEMDA 2013: Panel says obtaining funding is challenging but not hopeless

Feb. 21, 2013
By Omar Ford

SEMDA 2013: Leahey: med-tech firms' voices still matter despite difficulties

Feb. 20, 2013
By Omar Ford
ATLANTA — Some would say that in recent years the landscape for med-tech has been littered with difficulties and challenges often resulting in many devicemakers feeling as if their voice has been diminished.
Read More
Previous 1 2 … 114 115 116 117 118 119 120 121 122 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing